Edesa Biotech (EDSA) Interest & Investment Income (2013 - 2026)
Edesa Biotech (EDSA) posted Interest & Investment Income of $275.00 for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 51.9% from $572.00 a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Interest & Investment Income (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Edesa Biotech was $949.00, down 95.0% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $2,558, down 98.3% from FY2024.
- Annual Interest & Investment Income shows a five-year compound annual growth rate of -41.6% (FY2020 to FY2025).
- In prior fiscal years, Edesa Biotech's Interest & Investment Income was $153,498 in FY2024 (-47.0%), $289,846 in FY2023 (+356.3%), $63,523 in FY2022 (+468.9%) and $11,165 in FY2021 (-70.4%).
- Quarterly Interest & Investment Income has run from a low of $47.00 in fiscal Q1 2026 to a high of $85,718 in fiscal Q2 2023 over five years.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was fiscal Q1 2023, with growth of 707.7%; the weakest was fiscal Q4 2025, with a decline of 99.7%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Edesa Biotech | 37.18 Mn | 37.18 Mn | - | 275.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 275.00 |
| Dec 31, 2025 | 47.00 |
| Sep 30, 2025 | 55.00 |
| Jun 30, 2025 | 572.00 |
| Mar 31, 2025 | 265.00 |
| Dec 31, 2024 | 1,666.00 |
| Sep 30, 2024 | 16,491.00 |
| Jun 30, 2024 | 32,848.00 |
| Mar 31, 2024 | 43,193.00 |
| Dec 31, 2023 | 60,966.00 |
| Sep 30, 2023 | 71,945.00 |
| Jun 30, 2023 | 82,754.00 |
| Mar 31, 2023 | 85,718.00 |
| Dec 31, 2022 | 49,429.00 |
| Sep 30, 2022 | 36,137.00 |
| Jun 30, 2022 | 17,518.00 |
| Mar 31, 2022 | 3,748.00 |
| Dec 31, 2021 | 6,120.00 |
| Sep 30, 2021 | 6,886.00 |
| Jun 30, 2021 | 2,610.00 |
API Access
Edesa Biotech Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();